Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04374630
Title Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (PROFECTA-II)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Laekna Limited

ovarian clear cell carcinoma

ovarian serous carcinoma

endometrioid ovary carcinoma

peritoneum cancer

fallopian tube cancer


Afuresertib + Paclitaxel


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.